New migraine prevention pill EVO756 enters Mid-Stage trial
Prevention
Recruiting now
This Phase 2 study tests whether a daily pill called EVO756 can prevent migraines in adults who have not had success with other preventive treatments. About 330 participants will receive either EVO756 or a placebo, and researchers will track how many migraine days they have each …
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC